Cyclooxygenase-2 expression correlates with apoptosis and angiogenesis in endometrial cancer tissue

Anticancer Research

Volumn 27, Issue 6 A, 2007, Pages 3765-3770

  Ohno, Satoshi ^a   Ohno, Yumiko ^a   Suzuki, Nobutaka ^a   Soma, Gen Ichiro ^b,c   Inoue, Masaki ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b TOKUSHIMA BUNRI UNIVERSITY   (Japan)

^c TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Angiogenesis; Apoptosis; Cyclooxygenase 2; Endometrial cancer; Prognosis

Indexed keywords

CD31 ANTIGEN; CYCLOOXYGENASE 2;

ADULT; AGED; ANGIOGENESIS; APOPTOSIS; CONFERENCE PAPER; CONTROLLED STUDY; ENDOMETRIUM CANCER; ENZYME LOCALIZATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; ANTIGENS, CD31; APOPTOSIS; CYCLOOXYGENASE 2; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION; HUMANS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; SURVIVAL RATE;

EID: 35348983911     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (24)

1. Turini ME and DuBois RN: Cyclooxygenase-2: a therapeutic target. Annu Rev Med 53: 35-57, 2002.
2. Ohno S, Ohno Y, Suzuki N, Inagawa H, Kohchi C, Soma G and Inoue M: Multiple roles of cyclooxygenase-2 in endometrial cancer. Anticancer Res 25: 3679-3687, 2005.
3. Nasir A, Boulware D, Kaiser HE, Lancaster JM, Coppola D, Smith PV, Hakam A, Siegel SE and Bodey B: Cyclooxygenase-2 (COX-2) expression in human endometrial carcinoma and precursor lesions and its possible use in cancer chemoprevention and therapy. In Vivo 21: 35-43, 2007.
4. Jabbour HN, Milne SA, Williams AR, Anderson RA and Boddy SC: Expression of COX-2 and PGE synthase and synthesis of PGE2 in endometrial adenocarcinoma: a possible autocrine/paracrine regulation of neoplastic cell function via EP2/EP4 receptors. Br J Cancer 28: 1023-1031, 2001.
5. Uotila PJ, Erkkola RU and Klemi PJ: The expression of cyclooxygenase-1 and -2 in proliferative endometrium and endometrial adenocarcinoma. Ann Med 34: 428-433, 2002.
6. Cao QJ, Einstein MH, Anderson PS, Runowicz CD, Balan R and Jones JG: Expression of COX-2, Ki-67, cyclin D1, and P21 in endometrial endometrioid carcinomas. Int J Gynecol Pathol 21: 147-154, 2002.
7. Fujiwaki R, Iida K, Kanasaki H, Ozaki T, Hata K and Miyazaki K: Cyclooxygenase-2 expression in endometrial cancer: correlation with microvessel count and expression of vascular endothelial growth factor and thymidine phosphorylase. Hum Pathol 33: 213-219, 2002.
8. Ferrandina G, Legge F, Ranelletti FO, Zannoni GF, Maggiano N, Evangelisti A, Mancuso S, Scambia G and Lauriola L: Cyclooxygenase-2 expression in endometrial carcinoma: correlation with clinicopathologic parameters and clinical outcome. Cancer 95: 801-807, 2002.
9. Landen CN Jr, Mathur SP, Richardson MS and Creasman WT: Expression of cyclooxygenase-2 in cervical, endometrial, and ovarian malignancies. Am J Obstet Gynecol 188: 1174-1176, 2003.
10. Jeon YT, Kang S, Kang DH, Yoo KY, Park IA, Bang YJ, Kim JW, Park NH, Kang SB, Lee HP and Song YS: Cyclooxygenase-2 and p53 expressions in endometrial cancer. Cancer Epidemiol Biomarkers Prev 13: 1538-1542, 2004.
11. Toyoki H, Fujimoto J, Sato E, Sakaguchi H and Tamaya T: Clinical implications of expression of cyclooxygenase-2 related to angiogenesis in uterine endometrial cancers. Ann Oncol 16: 51-55, 2005.
12. Ohno Y, Ohno S, Suzuki N, Kamei T, Inagawa H, Soma G and Inoue M: Role of cyclooxygenase-2 in immunomodulation and prognosis of endometrial carcinoma. Int J Cancer 114: 696-701, 2005.
13. Ferrandina G, Ranelletti FO, Gallotta V, Martinelli E, Zannoni GF, Gessi M and Scambia G: Expression of cyclooxygenase-2 (COX-2), receptors for estrogen (ER), and progesterone (PR), p53, Ki67, and neu protein in endometrial cancer. Gynecol Oncol 98: 383-389, 2005.
14. Kilic G, Gurates B, Garon J, Kang H, Arun B, Lampley CE, Kurzel R and Ashfaq R: Expression of cyclooxygenase-2 in endometrial adenocarcinoma. Eur J Gynaecol Oncol 26: 271-274, 2005.
15. Li W, Xu RJ, Zhang HH and Jiang LH: Overexpression of cyclooxygenase-2 correlates with tumor angiogenesis in endometrial carcinoma. Int J Gynecol Cancer 16: 1673-1678, 2006.
16. Erkanli S, Bolat F, Kayaselcuk F, Demirhan B and Kuscu E: COX-2 and survivin are overexpressed and positively correlated in endometrial carcinoma. Gynecol Oncol 104: 320-325, 2007.
17. Pecorelli S, Benedet JL, Creasman WT and Shepherd JH: FIGO staging of gynecologic cancer. 1994-1997 FIGO Committee on Gynecologic Oncology. International Federation of Gynecology and Obstetrics. Int J Gynaecol Obstet 64: 5-10, 1999.
18. Yoshinaka R, Shibata MA, Morimoto J, Tanigawa N and Otsuki Y: COX-2 inhibitor celecoxib suppresses tumor growth and lung metastasis of a murine mammary cancer. Anticancer Res 26: 4245-4254, 2006.
19. Sheng H, Shao J, Morrow JD, Beauchamp RD and DuBois RN: Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res 58: 362-366, 1998.
20. Cao Y and Prescott SM: Many actions of cyclooxygenase-2 in cellular dynamics and in cancer. J Cell Physiol 190: 279-286, 2002.
21. Chan TA, Morin PJ, Vogelstein B and Kinzler KW: Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis. Proc Natl Acad Sci USA 95: 681-686, 1998.
22. Sheng H, Shao J, Washington MK and DuBois RN: Prostaglandin E2 increases growth and motility of colorectal carcinoma cells. J Biol Chem 276: 18075-18081, 2001.
23. St-Germain ME, Gagnon V, Mathieu I, Parent S and Asselin E: Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells. Int J Oncol 24: 1311-1324, 2004.
24. St-Germain ME, Gagnon V, Parent S and Asselin E: Regulation of COX-2 protein expression by Akt in endometrial cancer cells is mediated through NF-kappaB/IkappaB pathway. Mol Cancer 3: 7, 2004.